Stockscreener 앱 받기
1.06
0.93%
-0.01
시간 외 거래:
1.06
전일 마감가:
$1.07
열려 있는:
$1.07
하루 거래량:
379.72K
Relative Volume:
0.78
시가총액:
$65.66M
수익:
-
순이익/손실:
$-73.79M
주가수익비율:
-0.5761
EPS:
-1.84
순현금흐름:
$-77.44M
1주 성능:
-3.64%
1개월 성능:
-6.19%
6개월 성능:
-24.29%
1년 성능:
-69.54%
1일 변동 폭
$1.00
$1.07
1주일 범위
$1.00
$1.14
52주 변동 폭
$0.8332
$5.3899
Pyxis Oncology Inc Stock (PYXS) Company Profile
명칭
Pyxis Oncology Inc
전화
(617) 221-9059
주소
321 HARRISON AVENUE, BOSTON
PYXS을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
PYXS
Pyxis Oncology Inc
|
1.06 | 65.05M | 0 | -73.79M | -77.44M | -1.84 |
|
VRTX
Vertex Pharmaceuticals Inc
|
366.54 | 98.88B | 11.42B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
563.00 | 58.84B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
438.93 | 56.12B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
661.83 | 41.20B | 3.05B | 1.28B | -614.78M | 19.58 |
|
ONC
Beone Medicines Ltd Adr
|
288.18 | 35.49B | 3.81B | -644.79M | -669.77M | -6.24 |
Pyxis Oncology Inc Stock (PYXS) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2024-11-21 | 다운그레이드 | William Blair | Outperform → Mkt Perform |
| 2024-11-08 | 개시 | Stephens | Overweight |
| 2024-08-08 | 개시 | Stifel | Buy |
| 2024-05-07 | 재개 | Jefferies | Buy |
| 2024-02-09 | 개시 | BTIG Research | Buy |
| 2024-01-23 | 개시 | Leerink Partners | Outperform |
| 2023-09-05 | 개시 | RBC Capital Mkts | Outperform |
| 2021-11-02 | 개시 | BofA Securities | Neutral |
| 2021-11-02 | 개시 | Credit Suisse | Outperform |
| 2021-11-02 | 개시 | Jefferies | Buy |
모두보기
Pyxis Oncology Inc 주식(PYXS)의 최신 뉴스
AI Trend Models Suggest Bounce for Pyxis Oncology Inc.Early Entry Picks Before News Breakout Reviewed - beatles.ru
Pyxis Oncology Inc. stock chart pattern explainedSector Rotation Outlook With Historical Summary - Newser
Custom strategy builders for tracking Pyxis Oncology Inc.Trading Opportunities Forecast by AI Insight - Newser
Pyxis Oncology Inc. stock prediction for this weekDaily Profit Watch With Forecast Confidence - Newser
Visual analytics tools that track Pyxis Oncology Inc. performanceFree Risk Managed Intraday Trade Alerts - Newser
Why Pyxis Oncology Inc. stock attracts strong analyst attentionFree Investment Strategy With Predictable Gains - Newser
How Pyxis Oncology Inc. stock performs during market volatilityGrowth Projection Summary for Long-Term Investors - Newser
Should you hold or exit Pyxis Oncology Inc. nowPrice Spike Prediction for Active Traders - Newser
Real time scanner hits for Pyxis Oncology Inc. explainedBuy Strategy Review With Performance Summary - Newser
Pyxis Oncology shares rise 4.36% after-hours after announcing revisions to patient enrollment for Phase 1 clinical trial. - AInvest
Pyxis Oncology Updates Phase 1 Trial Enrollment: What You Need to Know - AInvest
Pyxis Oncology updates patient enrollment for Phase 1 trial of micvotabart pelidotin - Investing.com
Pyxis Oncology Updates Phase 1 Trial Enrollment - TipRanks
How to integrate Pyxis Oncology Inc. into portfolio analysis toolsImmediate Entry Point Prediction Strategy - Newser
How does Pyxis Oncology Inc. compare to its industry peersBreakthrough capital growth - Jammu Links News
What are analysts’ price targets for Pyxis Oncology Inc. in the next 12 monthsBreakthrough capital growth - Jammu Links News
What are the technical indicators suggesting about Pyxis Oncology Inc.Unlock daily trading alerts for profits - Jammu Links News
Should I hold or sell Pyxis Oncology Inc. stock in 2025Outstanding capital returns - Jammu Links News
What makes Pyxis Oncology Inc. stock price move sharplyDynamic profit opportunities - Jammu Links News
Pyxis Oncology Inc. Stock Analysis and ForecastBuild capital through low-risk investments - Jammu Links News
Will Pyxis Oncology Inc. outperform the marketHigh Accuracy Trade Setup Identification - Newser
What institutional investors are buying Pyxis Oncology Inc. stockFastest return on investment - Jammu Links News
What is Pyxis Oncology Inc. company’s growth strategyInvest smarter with expert stock picks - Jammu Links News
We Think Pyxis Oncology (NASDAQ:PYXS) Needs To Drive Business Growth Carefully - uk.finance.yahoo.com
Can Pyxis Oncology Inc. recover in the next quarterFree Reversal Alert Based on RSI Indicator - Newser
Pyxis Oncology Inc. Consolidation Zone May Signal AccumulationLow Capital High Return Stock Plans Reviewed - metal.it
What high frequency data says about Pyxis Oncology Inc.Weekly Watchlist of High Movers Released - metal.it
Live Scanner Shows Breakout on Pyxis Oncology Inc.Stock Selection With High Accuracy Based on Models - metal.it
Risk adjusted return profile for Pyxis Oncology Inc. analyzedSmart Trade Forecast Based on Neural Logic - Newser
Bullish Candlestick Pattern Forms in Pyxis Oncology Inc.Real Time Alerts Based on AI Prediction Triggered - metal.it
Chartists See Breakout Potential in Pyxis Oncology Inc.Growth Focused Entry Plan Suggestions Issued - metal.it
Price action breakdown for Pyxis Oncology Inc.Stable Entry High Return Opportunities in Focus - metal.it
When is Pyxis Oncology Inc. stock expected to show significant growthEarnings Report Outlook For 2025 - Jammu Links News
What is the dividend policy of Pyxis Oncology Inc. stockTremendous financial leverage - Jammu Links News
Will Pyxis Oncology Inc. Stock Benefit from AI and Green Energy TrendsHigh Reward Risk Balanced Trading - Newser
Key External Factors That Drive Pyxis Oncology Inc. Stock Price MovementsFree Access to Community with 300% Return - Newser
Is Pyxis Oncology Inc. a good long term investmentFree Real-Time Stock Data - PrintWeekIndia
Pyxis Oncology Inc (PYXS) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.24%
3.39%
자본화:
|
볼륨(24시간):